Patents Assigned to MetaModix, Inc.
  • Publication number: 20130030351
    Abstract: Several gastrointestinal surgery procedures are effective as treatments for metabolic disorders such as obesity and diabetes. Minimally invasive procedures including intra-luminal gastrointestinal implants have been proposed to mimic the anatomical, physiological and metabolic changes achieved by these procedures. Many of these designs include long sleeve like elements that prevent contact of food with the walls of the small intestine. It is desirable to have simple delivery systems that can place these implants under endoscopic guidance. However, in order to anchor these sleeve elements safely and reliably, the inventors have previously disclosed anchoring means that anchor the sleeves at the junctions of the stomach and the intestine or the stomach and esophagus.
    Type: Application
    Filed: September 30, 2012
    Publication date: January 31, 2013
    Applicant: MetaModix, Inc.
    Inventor: MetaModix, Inc.
  • Publication number: 20120302936
    Abstract: Components may be used separately or in combination to create anchoring systems for intra-luminal implants for the treatment of metabolic disorders such as obesity and diabetes. Various systems include an external component adapted for deployment around a portion of the gastrointestinal tract (e.g., the duodenum) and an internal component adapted for implantation within the gastrointestinal tract. Various systems use anchoring means that are based on mechanical interference, elasticity, spring force, shape memory transformation, magnetic attraction, repulsion and/or levitation. Various embodiments rely on longitudinal anchoring of the implants with minimal force against tissue.
    Type: Application
    Filed: August 6, 2012
    Publication date: November 29, 2012
    Applicant: MetaModix, Inc.
    Inventors: Kedar R. Belhe, Paul J. Thompson
  • Patent number: 8282598
    Abstract: Components may be used separately or in combination to create anchoring systems for intra-luminal implants for the treatment of metabolic disorders such as obesity and diabetes. Various systems include an external component adapted for deployment around a portion of the gastrointestinal tract (e.g., the duodenum) and an internal component adapted for implantation within the gastrointestinal tract. Various systems use anchors that are based on mechanical interference, elasticity, spring force, shape memory transformation, magnetic attraction, repulsion and/or levitation. Various embodiments rely on longitudinal anchoring of the implants with minimal force against tissue.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: October 9, 2012
    Assignee: MetaModix, Inc.
    Inventors: Kedar R. Belhe, Paul J. Thompson
  • Publication number: 20120253259
    Abstract: A modular system for therapy within a gastrointestinal system. The system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This modular design allows the physician to tailor the therapy to the patient's needs. The modular system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM.
    Type: Application
    Filed: June 11, 2012
    Publication date: October 4, 2012
    Applicant: MetaModix, Inc.
    Inventors: Kedar R. Belhe, Paul J. Thompson
  • Publication number: 20120253260
    Abstract: A system for therapy within a gastrointestinal system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This design allows the physician to tailor the therapy to the patient's needs. The system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM.
    Type: Application
    Filed: June 12, 2012
    Publication date: October 4, 2012
    Applicant: MetaModix, Inc.
    Inventors: Kedar R. Belhe, Paul J. Thompson
  • Publication number: 20120184893
    Abstract: A gastrointestinal device for implanting within a pylorus, a duodenal bulb, and a duodenum of a patient's gastrointestinal tract includes an expandable structure including a proximal portion having a plurality of spring arms and a distal portion having a plurality of spring arms, the proximal and distal portions coupled by a rigid central cylinder having a diameter capable of fitting within the pylorus and having a length greater than a width of the pylorus. An intestinal bypass sleeve is coupled to at least one of the proximal and distal portions of the expandable structure and having a length sufficient to extend at least partially into the duodenum. In the expanded configuration, the proximal portion has a diameter larger than a maximum opening diameter of the pylorus and further wherein, in the expanded configuration, the distal portion has a diameter larger than a maximum opening diameter of the pylorus.
    Type: Application
    Filed: January 28, 2012
    Publication date: July 19, 2012
    Applicant: MetaModix, Inc.
    Inventors: Paul J. Thompson, Kedar R. Belhe, Alexander D. Grafov
  • Patent number: 8211186
    Abstract: A modular system for therapy within a gastrointestinal system. The system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This modular design allows the physician to tailor the therapy to the patient's needs. The modular system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM.
    Type: Grant
    Filed: April 1, 2010
    Date of Patent: July 3, 2012
    Assignee: MetaModix, Inc.
    Inventors: Kedar R. Belhe, Paul J. Thompson
  • Publication number: 20120065571
    Abstract: A gastrointestinal device for implanting within a patient's gastrointestinal tract includes first and second expandable anchoring rings configured to be disposed on either side of a patient's pylorus. The first expandable anchoring ring has a collapsed configuration and an expanded configuration, wherein in the expanded configuration the first expandable anchoring ring has a diameter larger than a maximum opening diameter of the pylorus. The second expandable anchoring ring also has a collapsed configuration and an expanded configuration, wherein in the expanded configuration the second expandable anchoring ring has a diameter larger than a maximum opening diameter of the pylorus. An intestinal bypass sleeve couples the first expandable anchoring ring and the second expandable anchoring ring, so as to allow a distance between the anchoring rings to exceed a width of the pylorus.
    Type: Application
    Filed: November 17, 2011
    Publication date: March 15, 2012
    Applicant: MetaModix, Inc.
    Inventors: Paul J. Thompson, Kedar R. Belhe, Alex Grafov
  • Publication number: 20110106273
    Abstract: A system of components may be used separately or in combination to create partial bypass of food, stomach and intestinal secretions and digestive enzymes. The systems are designed to be modular so as to allow the physicians to quickly replace certain elements to tailor the amount of material bypassed, the restriction applied to food passage, and the origin and destination of bypass according to the patient's individualized clinical needs.
    Type: Application
    Filed: January 7, 2011
    Publication date: May 5, 2011
    Applicant: MetaModix, Inc.
    Inventors: Kedar R. Belhe, Paul J. Thompson
  • Publication number: 20110009690
    Abstract: Components may be used separately or in combination to create anchoring systems for intra-luminal implants for the treatment of metabolic disorders such as obesity and diabetes. Various systems include an external component adapted for deployment around a portion of the gastrointestinal tract (e.g., the duodenum) and an internal component adapted for implantation within the gastrointestinal tract. Various systems use anchoring means that are based on mechanical interference, elasticity, spring force, shape memory transformation, magnetic attraction, repulsion and/or levitation. Various embodiments rely on longitudinal anchoring of the implants with minimal force against tissue.
    Type: Application
    Filed: July 9, 2010
    Publication date: January 13, 2011
    Applicant: MetaModix, Inc.
    Inventors: Kedar R. Belhe, Paul J. Thompson
  • Publication number: 20100256775
    Abstract: A modular system for therapy within a gastrointestinal system. The system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This modular design allows the physician to tailor the therapy to the patient's needs. The modular system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM.
    Type: Application
    Filed: April 1, 2010
    Publication date: October 7, 2010
    Applicant: MetaModix, Inc.
    Inventors: Kedar R. Belhe, Paul J. Thompson